Company Overview and News

0
Hope for those planning to own a home

2018-07-14 thestar.com.my
THE government’s initiative to encourage the young and the financially-rickety to be homeowners through affordable housing projects is making many feel hopeful.
5932

0
SKH to buy 70% stake in firm to gain rights to affordable housing project

2018-07-12 theedgemarkets
KUALA LUMPUR (July 12): SKH Consortium Bhd is planning to acquire a 70% stake in property development firm Rimbun Gabungan Sdn Bhd for RM12 million, from a company in which Bina Puri Holdings Bhd's founder Dr Tony Tan Cheng Kiat is a director.
5932

0
WCT, Lafarge Malaysia, Star Media Group, JAKS Resources, Gabungan AQRS, Atlan, Kumpulan Jetson, Nova MSC and SKH Consortium

2018-07-12 theedgemarkets
KUALA LUMPUR (July 12): Based on corporate announcements and news flow today, companies in focus on Friday (July 13) may include: WCT, Lafarge Malaysia, Star Media Group, JAKS Resources, Gabungan AQRS, Atlan, Kumpulan Jetson, Nova MSC and SKH Consortium.
5932 5226 6084 3751 0026 4723 9083 1800 9679 3794

2
Bina Puri hopes to sustain momentum despite property slump

2018-07-02 theedgemarkets
KUALA LUMPUR: Construction company Bina Puri Holdings Bhd is hoping to sustain last year’s financial performance at the very least, given that the property market remains tepid, while drastic cost cuts by the new Pakatan Harapan government have derailed several key projects.
5932

2
Toll dilemma

2018-05-17 thestar.com.my
PETALING JAYA: With the Government expected to make announcements on changes to toll charges on expressways, attention will be focused on the impact this may have on concessionaires and the national finances.
5932 6645 7078

3
Trading ideas: Vertice, Lee Swee Kiat Group, Bina Puri

2018-04-04 thestar.com.my - 1
KUALA LUMPUR: Vertice Bhd , Lee Swee Kiat Group Bhd and Bina Puri Holdings Bhd are among the stocks to watch on Wednesday, according to JF Apex Research.
5932 8079

6
Bina Puri unit to develop two hydropower sites in Sabah

2018-04-04 thestar.com.my
PETALING JAYA: Property and construction outfit Bina Puri Holdings Bhd has inked a deal with Warisan Harta Sabah Sdn Bhd to develop two small hydropower sites in Kota Belud, Sabah.
5932 BSMAF 1818

2
Trading ideas: Scientex, Advancecon, Bina Puri, Titijaya, Muhibbah

2018-03-23 thestar.com.my
KUALA LUMPUR: Scientex Bhd , Advancecon Holdings Bhd, Bina Puri Holdings Bhd , Titijaya Land Bhd and Muhibbah Engineering (M) Bhd are among the stocks to watch on Friday, according to JF Apex Research.
5239 5932 5703 2593

6
Bina Puri, Titijaya in joint venture

2018-03-23 thestar.com.my
PETALING JAYA: Bina Puri Holdings Bhd and Titijaya Land Bhd are entering into a new joint venture (JV) to develop a mixed residential and commercial project on 11.2 acres of land in Brickfields, Kuala Lumpur.
5239 5932 BSMAF 1818

Related Articles

REPH: Recro Pharma Analysis and Research Report

2018-08-20 - Asif

Overview Recro Pharma is a specialty pharmaceutical company that operates through two business divisions: an Acute Care division and a revenue-generating CDMO division. Each of these divisions are deemed to be reportable segments for financial reporting purposes. The company's Acute Care segment is primarily focused on developing and commercializing innovative products for hospital and related acute care settings. The company's lead product candidate is a proprietary injectable form of meloxicam, a long-acting preferential COX-2 inhibitor. IV meloxicam has successfully completed three Phase III clinical trials for the management of moderate to severe pain, consisting of two pivotal efficacy trials and a large double-blind Phase III safety trial, as well as other safety studies. Overall, the total new drug application, or NDA, program included over 1,400 patients. In late July 2017, the company submitted a NDA to the U.S. Food and Drug Administration, or FDA, for IV meloxicam...

ACHN: Achillion Pharmaceuticals Analysis and Research Report

2018-08-20 - Asif

Overview Achillion Pharmaceuticals is a clinical-stage biopharmaceutical company focused on advancing its oral factor D inhibitors into late-stage development and commercialization. Each of the drug candidates in its oral factor D portfolio was discovered in its laboratories and is wholly owned by it. Achillion Pharmaceuticals is focusing its drug development activities on alternative pathway-mediated, rare diseases where there are no approved therapies or where existing therapies are inadequate for patients. To advance its investigational drugs into phase III and commercialization, the company plan to work closely with key stakeholders including patients, payors, regulators and healthcare professionals. The company's first-generation factor D inhibitor, ACH-4471, has demonstrated preliminary clinical proof-of-concept in patients with C3 glomerulopathy, or C3G, a disease affecting the kidney, and paroxysmal nocturnal hemoglobinuria, or PNH, a blood disorder, and has advanced...

BTE: Baytex Energy Trust Analysis and Research Report

2018-08-20 - Asif

General Baytex Energy Corp. was incorporated on October 22, 2010 pursuant to the provisions of the ABCA. Baytex is the successor to the business of Baytex Energy Trust, which was transitioned to Baytex on December 31, 2010. Inter-Corporate Relationships The following table provides the name, the percentage of voting securities owned by it and the jurisdiction of incorporation, continuance, formation or organization of its material subsidiaries either, direct and indirect, as at the date hereof. ||Percentage of voting securities (directly or indirectly)|Jurisdiction of Incorporation/Formation| | ------------ | ------------: | :------------: | |Baytex Energy Ltd.|100%|Alberta| |Baytex Energy USA, Inc.|100%|Delaware| |Baytex Energy Partnership|100%|Alberta| Organizational Structure The following simplified diagram shows the inter-corporate relationships among it and its material subsidiaries as of the date hereof. <img src="https://www.sec.gov/A...